Medway NHS Foundation Trust has partnered with Digostics to offer home oral glucose tolerance testing (OGTT) technology to all at-risk expectant mothers. The initiative aims to transform the screening ...
Digostics Limited, a leading digital clinical diagnostics and diabetes home testing provider, has announced a new commercial partnership with leading diabetes technology company, AgaMatrix Europe ...
Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1 diabetes (T1D) in ...
OXFORD, England--(BUSINESS WIRE)--New research published in Diabetic Medicine this week found that the standard NHS procedures for processing gestational diabetes blood sugar tests were leading to ...
Digostics, a biotech developing the world's first at-home oral glucose tolerance test for diabetes, has raised £520,474 and counting from 108 investors on crowdfunding platform Crowdcube. The ...
"Digostics is excited to work with UHS to explore how GDM screening can be streamlined through home-testing," said James Jackson, CEO and Founder, Digostics. " Our aim is to demonstrate how we can ...
Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance Home Testing GTT@home represents the world's first and only ...
OXFORD, UK / ACCESSWIRE / February 21, 2024 / Digital clinical diagnostics and diabetes home testing provider Digostics revealed today the results from its ground-breaking gestational diabetes ...
The UK’s National Institute for Health & Care Research (NIHR) Oxford Biomedical Research Centre is set to initiate a study into a new at-home test for diagnosing type 1 diabetes (T1D) in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results